Thymosin beta-10 is aberrantly expressed in pancreatic cancer and induces JNK activation

Cancer Investigation

Volumn 27, Issue 3, 2009, Pages 251-256

  Li, Min ^a   Zhang, Yuqing ^a   Zhai, Qihui ^b   Feurino, Louis W ^a   Fisher, William E ^a   Chen, Changyi ^a   Yao, Qizhi ^a   DeBakey, Michael E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Pancreatic cancer; T 10

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 8; PHOSPHOPROTEIN; STRESS ACTIVATED PROTEIN KINASE; THYMOSIN BETA10; CYTOKINE; THYMOSIN; THYMOSIN BETA(10);

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CYTOKINES; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; PANCREATIC NEOPLASMS; PHOSPHORYLATION; THYMOSIN;

EID: 63349110389     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802254016     Document Type: Article

References (33)

1. Yu, F.X.; Lin, S.C.; Morrison-Bogorad, M.; Yin, H.L. Effects of thymosin beta 4 and thymosin beta10 on actin structures in living cells. Cell Motil Cytoskel 1994, 27, 13-25. (Pubitemid 24036377)
2. Santelli, G.; Califano, D.; Chiappetta, G.; Vento, M.T.; Bartoli, P.C.; Zullo, F.; et al. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 1999, 155, 799-804. (Pubitemid 29426825)
3. Bodey, B.; Bodey, B., Jr.; Siegel, S.E.; Kaiser, H.E. Reviewof thymic hormones in cancer diagnosis and treatment. Int J Immunopharmacol 2000, 22, 261-273. (Pubitemid 30109504)
4. Erickson-Viitanen, S.; Ruggieri, S.; Natalini, P.; Horecker, B.L. Thymosin beta 10, a new analog of thymosin beta 4 in mammalian tissues. Arch Biochem Biophys 1983, 225, 407-413.
5. Hall, A.K. Thymosin beta-10 accelerates apoptosis. Cell Mol Biol Res 1995, 41, 167-180.
6. Yu, F.X.; Lin, S.C.; Morrison-Bogorad, M.; Atkinson, M.A.; Yin, H.L. Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J Biol Chem 1993, 268, 502-509. (Pubitemid 23021350)
7. Liu, C.R.; Ma, C.S.; Ning, J.Y.; You, J.F.; Liao, S.L.; Zheng, J. Differential thymosin beta 10 expression levels and actin filament organization in tumor cell lines with different metastatic potential. Chin Med J (Engl) 2004, 117, 213-218. (Pubitemid 38351446)
8. Oien, K.A.; Vass, J.K.; Downie, I.; Fullarton, G.; Keith, W.N. Profiling, comparison, and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 2003, 22, 4287-4300 (Pubitemid 36876249)
9. Verghese-Nikolakaki, S.; Apostolikas, N.; Livaniou, E.; Ithakissios, D.S.; Evangelatos, G.P. Preliminary findings on the expression of thymosin beta-10 in human breast cancer. Br J Cancer 1996, 74, 1441-1444. (Pubitemid 26370737)
10. Hall, A.K. Amplification-independent overexpression of thymosin beta-10 mRNA in human renal cell carcinoma. Ren Fail 1994, 16, 243-254.
11. Weterman, M.A.; van Muijen, G.N.; Ruiter, D.J.; Bloemers, H.P. Thymosin beta-10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanoma. Int J Cancer 1993, 53, 278-284.
12. Hall, A.K. Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer 1991, 48, 672-677.
13. Takano, T.; Hasegawa, Y.; Miyauchi, A.; Matsuzuka, F.; Yoshida, H.; Kuma, K.; et al. Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas. Jpn J Clin Oncol 2002, 32, 229-232. (Pubitemid 43102804)
14. Califano, D.; Monaco, C.; Santelli, G.; Giuliano, A.; Veronese, M.L.; Berlingieri, M.T.; et al. Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res 1998, 58, 823-828.
15. Santelli, G.; Bartoli, P.C.; Giuliano, A.; Porcellini, A.; Mineo, A.; Barone, M.V.; et al. Thymosin beta-10 protein synthesis suppression reduces the growth of human thyroid carcinoma cells in semisolid medium. Thyroid 2002, 12, 765-772.
16. Alldinger, I.; Dittert, D.; Peiper, M.; Fusco, A.; Chiappetta, G.; Staub, E.; et al. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer. Pancreatology 2005, 5, 370-379. (Pubitemid 41160274)
17. Furukawa, T.; Duguid, W.P.; Rosenberg, L.; Viallet, J.; Galloway, D.A.; Tsao, M.S. Long-termculture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 1996, 148, 1763-1770.
18. Ouyang, H.; Mou, L.; Luk, C.; Liu, N.; Karaskova, J.; Squire, J.; et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 2000, 157, 1623-1631.
19. Li, M.; Yang, H.; Chai, H.; Fisher, W.E.; Wang, X.; Brunicardi, F.C.; et al. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer 2004, 101, 2341-2350. (Pubitemid 39458692)
20. Li, M.; Zhai, Q.; Bharadwaj, U.; Wang, H.; Li, F.; Fisher, W.E.; et al. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 2006, 106, 2284-2294. (Pubitemid 43673252)
21. Li, M.; Zhang, Y.; Liu, Z.; Bharadwaj, U.; Wang, H.; Wang, X.; et al. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci USA 2007, 104, 18636-18641.
22. Macchi, P.; Villa, A.; Giliani, S.; Sacco, M.G.; Frattini, A.; Porta, F.; et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995, 377, 65-68.
23. Uehira, M.; Matsuda, H.; Nakamura, A.; Nishimoto, H. Immunologic abnormalities exhibited in IL-7 transgenic mice with dermatitis. J Invest Dermatol 1998, 110, 740-745. (Pubitemid 28194020)
24. Lambeck, A.J.; Crijns, A.P.; Leffers, N.; Sluiter, W.J.; ten Hoor, K.A.; Braid, M.; et al. Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin-7. Clin Cancer Res 2007, 13, 2385-2391.
25. Farrow, B.; Sugiyama, Y.; Chen, A.; Uffort, E.; Nealon, W.; Mark Evers, B. Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg 2004, 239, 763-769; discussion, 769-771.
26. Xie, K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 2001, 12, 375-391.
27. Varney, M.L.; Johansson, S.L.; Singh, R.K. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am J Clin Pathol 2006 125, 209-216.
28. Luca, M.; Huang, S.; Gershenwald, J.E.; Singh, R.K.; Reich, R.; Bar-Eli, M. Expression of interleukin-8 by human melanoma cells upregulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 1997, 151, 1105-1113. (Pubitemid 27424320)
29. Furuya, M.; Suyama, T.; Usui, H.; Kasuya, Y.; Nishiyama, M.; Tanaka, N.; et al. Upregulation ofCXCchemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis. Hum Pathol 2007, 38, 1676-1687 (2007).
30. Gorelik, E.; Landsittel, D.P.; Marrangoni, A.M.; Modugno, F.; Velikokhatnaya, L.; Winans, M.T.; et al. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005, 14, 981-987. (Pubitemid 40478567)
31. Yurkovetsky, Z.R.; Kirkwood, J.M.; Edington, H.D.; Marrangoni, A.M.; Velikokhatnaya, L.; Winans, M.T.; et al. Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b. Clin Cancer Res 2007, 13, 2422-2428.
32. Xie, K.; Wei, D.; Huang, S. Transcriptional antiangiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev 2006, 17, 147-156. (Pubitemid 43816895)
33. Bellone, G.; Smirne, C.; Mauri, F.A.; Tonel, E.; Carbone, A.; Buffolino, A.; et al. Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. Cancer Immunol Immunother 2006, 55, 684-698.